Page 10 - Jon Rees News Today

Lick Observatory support astronomer Jon Rees offers tips on when and how to view the meteor shower, which will peak later this week.

MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the progression of degenerative diseases, announces the close of its seed financing. Financial details are not disclosed ...

/PRNewswire/ -- MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the...

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

A biotech company which aims to harness University of Exeter research to develop new therapeutics to stop the progression of degenerative diseases has received new seed financing. MitoRx Therapeutics (MitoRx), is initially focussing on developing a n

/PRNewswire/ -- MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the...

- MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the progression of degenerative diseases, announces the close of its seed financing.

Sunburn — The morning read of what’s hot in Florida politics — 6.3.21 Good Thursday morning. A top-of-Sunburn birthday shoutout to my brother from another mother,  Reggie Cardozo. Florida and D.C. politics know Reggie as a former Obama White House staffer and a top-flight political strategist, but I know him as a dedicated husband to Stephanie, father to Fallon, and Sutton James, and a trusted friend to many. He’s also my boat buddy, a fellow connoisseur of Bloody Marys a...

 E-Mail Scientists have identified a way to "rescue" muscle cells that have genetically mutated, paving the way to a possible new treatment for rare childhood illness such as Duchenne Muscular Dystrophy (DMD). The study, led by the Universities of Exeter and Nottingham, is published in the Proceedings of the National Academies of Sciences, USA. The research used novel drugs being developed at the University of Exeter, which "metabolically reprogram" the cellular energy production centres in ...

GP reveals huge frustration over Bristol vaccine supply The situation needs to improve for the coronavirus vaccine effort to get "anywhere near" the mid-February target, says Dr Jon Rees THE BIGGEST STORIES ACROSS BRISTOL IN YOUR INBOXInvalid EmailSomething went wrong, please try again later. SIGN UP When you subscribe we will use the information you provide to send you these newsletters. Sometimes they’ll include recommendations for other related newsletters or services we offer. OurPrivacy ...